Searched for: in-biosketch:yes
person:allenj01
Metrizamide washout as a measure of CSF bulk flow
Rottenberg DA; Deck MD; Allen JC
Metrizamide was injected into the ventricular system of three adults and five children with indwelling ventricular catheters and subcutaneous CSF reservoirs. A first-order rate constant, k, for metrizamide washout from one lateral ventricle was determined with reference to ventricular metrizamide concentration on serial (up to six) postinjection CT scans. Lateral ventricular volume, Vv, was estimated after metrizamide injection by a planimetric method and by partial volume analysis, an interactive computerized technique. The rate of lateral ventricular CSF formation, If, was calculated as k X Vv and ranged from 0.0622 to 0.103 ml/min. Precise measurements of lateral ventricular CSF bulk flow depend upon adequate mixing of the injected contrast material with ventricular CSF and accurate measurements of lateral ventricular volume
PMID: 310979
ISSN: 0028-3940
CID: 57750
Determination of ventricular volume following metrizamide CT ventriculography
Rottenberg DA; Pentlow KS; Deck MD; Allen JC
Volume averaging, relatively slight differences in the mean attenuation coefficients of CSF and white/grey matter, and the irregular contours of the human ventricular system have so far seriously limited the accuracy of CT estimation of ventricular volume. Taking advantage of the high attenuation of metrizamide-containing CSF, we have developed three methods for computing ventricular volume after metrizamide CT ventriculography; these methods depend upon computer analysis of X-ray absorption data obtained from contiguous CT brain slices. All three methods were validated by CT scanning a formalin-fixed cadaver brain containing an apoxy-resin cast of the ventricular system. Calculated ventricular volumes were compared with the actual measured volume of the ventricular cast
PMID: 310976
ISSN: 0028-3940
CID: 57751
RESPONSE OF INTRA CRANIAL NEOPLASMS TO HIGH DOSE METHOTREXATE WITH CITROVORUM FACTOR RESCUE
ROSEN G; GHAVIMI F; ALLEN J; DECK M
BIOSIS:PREV197814000373
ISSN: 0047-6706
CID: 131903
Dopaminergic function in Gilles de la Tourette's syndrome, Sydenham's chorea and torsion dystonia
Lal S; Allen J; Etienne P; Sourkes TL; Humphreys P
PMID: 1070416
ISSN: 0303-8467
CID: 57813
Cerebrospinal fluid T and B lymphocyte kinetics related to exacerbations of multiple sclerosis
Allen JC; Sheremata W; Cosgrove JB; Osterland K; Shea M
Cerebrospinal fluid T and B lymphocyte populations were identified in 21 patients with relapsing and 10 patients with stable multiple sclerosis. The results indicate that the percentage of T cell is largest in the acute stage of a relapse (65 percent) and diminishes by the second week (41 percent). Conversely, the stable patients had a lower percentage of T cells (30 percent) and a relatively high percentage of nonreacting cells (66 percent). The proportion of T cells in the cerebrospinal fluid varies directly with the clinical activity of the disorder, further implicating cellular immune mechanisms in the pathogenesis of multiple sclerosis
PMID: 1084494
ISSN: 0028-3878
CID: 57745
The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features
Karpati G; Carpenter S; Engel AG; Watters G; Allen J; Rothman S; Klassen G; Mamer OA
An 11-year old boy had had recurrent episodes of hepatic and cerebral dysfunction and underdeveloped musculature. Overt weakness developed at age 10. Lipid excess, especially in type I fibers, was found in muscle. Hypertrophied smooth endoplasmic reticulum and excessive microbodies were present in liver. Marked carnitine deficiency was shown in skeletal muscle, plasma, and liver. Ketogenesis was impaired on a high fat diet, but omega oxidation of fatty acids was enhanced. There was excessive glucose uptake and essentially no oxidation of labeled long-chain fatty acids by perfused forearm muscles in vivo. Oral replacement therapy restored plasma carnitine levels to normal, but not liver or muscle carnitine levels, and was accompanied by clinical improvement
PMID: 234182
ISSN: 0028-3878
CID: 57812
Acoustic neuroma in the last months of pregnancy
Allen J; Eldridge R; Koerber T
PMID: 4842596
ISSN: 0002-9378
CID: 57811
Early-onset neuroma: genetic, clinical and nosologic aspects
Allen JC; Eldridge R; Young D
PMID: 4462630
ISSN: 0547-6844
CID: 57744